Christopher Steele serves as the Chief of Strategy at the Medical Technology Enterprise Consortium (MTEC), where he leads strategic initiatives to advance biotech/medtech solutions that support dual-use (military and civilian) medical applications. In this role, Steele drives the non-profit organization’s efforts to expand MTEC’s program customer base, pursue & partner across federal opportunities, and strengthen MTEC’s financial and reputational standing as the go-to “Other Transaction” mechanism for DoD medical product maturation and commercialization. His leadership ensures that MTEC remains at the forefront of medical innovation, while building a sustainable and diverse entity. With over 34 years of service in the Department of Defense (in the US Army and US Navy), Steele held key leadership roles in research and development. He directed the Military Operational Medicine Research Program (MOMRP) for Army and Defense Health Agency funding and was a Program Officer at the Office of Naval Research. Additionally, he played a pivotal role in joint R&D funding and Navy/Marine Corps prioritization efforts at the Navy Bureau of Medicine and Surgery. His experience includes overseeing +$1Bn of R&D funding and hundreds of medical research projects (across 11 intramural DoD laboratories, several UARCs and FFRDCs, and many academic and commercial partners) aimed at improving the health, readiness, and performance of Servicemembers.
